NCT07010887

Brief Summary

Military service members frequently experience repetitive insults or impacts to the head (RHIs). The purpose of the proposed randomized controlled trial is to understand how time intervals affect neurological responses to repetitive subconcussive head impacts.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Aug 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Aug 2025Sep 2028

First Submitted

Initial submission to the registry

May 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 8, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

August 5, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

3.1 years

First QC Date

May 30, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Subconcussive brain injuryTBISoccer HeadingTime Interval

Outcome Measures

Primary Outcomes (7)

  • Blood Biomarkers - NfL

    The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically NF-L (neurofilament light).

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Blood Biomarkers - GFAP

    The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically GFAP (glial fibrillary acidic protein; nanograms per milliliter).

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Blood Biomarkers - pTau

    The primary outcome analyses will be comparing group differences (group x time interactions) in blood biomarkers, specifically phosphorylated tau (picogram per milliliter).

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Optical Coherence Tomography/Angiography (OCT/A) 1

    Retinal neural structure will be imaged in one or both eyes using high-definition spectral domain OCT, which will be acquired using a Zeiss Cirrus OCT scanner. The primary OCT variables examined will be macula CSF thickness (an indicator of the gain or loss of neurons or glia in the inner nuclear, ganglion cell and nerve fiber layer). Retinal vascular structure will be acquired using the OCT angiography (OCT/A) capability of the Cirrus.

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Optical Coherence Tomography/Angiography (OCT/A) 2

    Retinal neural structure will be imaged in one or both eyes using high-definition spectral domain OCT, which will be acquired using a Zeiss Cirrus OCT scanner. The primary OCT variables examined will be cup-to-disc ratio (an indicator of neurodegeneration at the optic disc).

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Optical Coherence Tomography/Angiography (OCT/A) 3

    Retinal vascular structure will be acquired using the OCT angiography (OCT/A) capability of the Cirrus. The primary OCT/A variable examined will be foveal avascular zone (FAZ) area reflecting the size of the central portion of the macula which contains no blood vessels, and which increases in size with loss of capillaries in the surrounding region).

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Quantitative Electroencephalography (qEEG)

    An Investigational version of the BrainScope FDA-cleared qEEG acquisition device will be used in this study. The investigational nature of the device is simply based on the code which does not produce a diagnostic result for the blinded researcher. Thus, the manufacturer's full device indications/labeling document will be the same as the FDA-cleared version. An eyes-closed resting EEG will be recorded. An FDA cleared multivariate EEG marker of concussion, the Concussion Index (CI) will be used as input for this study modeling. The CI includes measures of power (absolute and relative), mean frequency, connectivity (asymmetry, coherence, phase lag, phase synchrony), complexity (fractal dimension and scale-free activity), and information theory (entropy), across and within frequency bands. Other features of interest will be included in the EEG data set. We will use all variables in a single model to analyze which variable, to what extent, contributed to group differences.

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

Secondary Outcomes (9)

  • Near Point of Convergence (NPC)

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Pupillary Size Measurement and Reactivity 1

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Pupillary Size Measurement and Reactivity 2

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Pupillary Size Measurement and Reactivity 3

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • Pupillary Size Measurement and Reactivity 4

    Baseline, 24 hours following the final heading session, 14 days following the final heading session

  • +4 more secondary outcomes

Study Arms (4)

Short Interval - heading

EXPERIMENTAL

Participants in the heading group will undergo 16 soccer headings, twice per week, with 24 hours in between each session.

Other: Short IntervalDevice: BrainScope qEEG

Long Interval - heading

EXPERIMENTAL

Participants in the heading group will undergo 16 soccer headings, twice per week, with 72 hours in between each session.

Other: Long IntervalDevice: BrainScope qEEG

Short Interval - kicking

SHAM COMPARATOR

Participants in the kicking-control group will undergo 16 soccer kicking, twice per week, with 24 hours in between each session.

Other: Short IntervalDevice: BrainScope qEEG

Long Interval - kicking

SHAM COMPARATOR

Participants in the kicking-control group will undergo 16 soccer kicking, twice per week, with 72 hours in between each session.

Other: Long IntervalDevice: BrainScope qEEG

Interventions

A standardized and reliable soccer heading protocol will be used for the experiment. Participants perform 16 headers or kicking with 1 header per 30 seconds. The sessions (twice per week for 4 weeks) will be separated by 24 hours.

Short Interval - headingShort Interval - kicking

A standardized and reliable soccer heading protocol will be used for the experiment. Participants perform 16 headers or kicking with 1 header per 30 seconds. The sessions (twice per week for 4 weeks) will be separated by 72 hours.

Long Interval - headingLong Interval - kicking

An Investigational version of the BrainScope FDA-cleared qEEG acquisition device will be used in this study. The investigational nature of the device is simply based on the code which does not produce a diagnostic result for the blinded researcher. Electrodes will be placed around the participant's forehead and scalp to acquire electrical readings of brain activity.

Long Interval - headingLong Interval - kickingShort Interval - headingShort Interval - kicking

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Current soccer player (intercollegiate, club, intramural, recreational).
  • At least 5 years of soccer heading experience (justification below).
  • Ability to provide informed consent without a legally authorized representative (LAR).

You may not qualify if:

  • Any head, neck, or face injury within the 6 months prior to enrollment, including concussions, that precludes participation in contact sports.
  • Participants with eye conditions or diseases that could impact the blood vessels in the eye -such as but not limited to: glaucoma, macular degeneration, diabetic retinopathy.
  • Determination that the participant is unsuitable for study entry or potentially unable to complete all aspects of the study based on the judgement of the Investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University School of Public Health

Bloomington, Indiana, 47405, United States

RECRUITING

Related Publications (12)

  • Marchi N, Bazarian JJ, Puvenna V, Janigro M, Ghosh C, Zhong J, Zhu T, Blackman E, Stewart D, Ellis J, Butler R, Janigro D. Consequences of repeated blood-brain barrier disruption in football players. PLoS One. 2013;8(3):e56805. doi: 10.1371/journal.pone.0056805. Epub 2013 Mar 6.

    PMID: 23483891BACKGROUND
  • Kawata K, Rubin LH, Takahagi M, Lee JH, Sim T, Szwanki V, Bellamy A, Tierney R, Langford D. Subconcussive Impact-Dependent Increase in Plasma S100beta Levels in Collegiate Football Players. J Neurotrauma. 2017 Jul 15;34(14):2254-2260. doi: 10.1089/neu.2016.4786. Epub 2017 Apr 27.

    PMID: 28181857BACKGROUND
  • Puvenna V, Brennan C, Shaw G, Yang C, Marchi N, Bazarian JJ, Merchant-Borna K, Janigro D. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits. PLoS One. 2014 May 7;9(5):e96296. doi: 10.1371/journal.pone.0096296. eCollection 2014.

    PMID: 24806476BACKGROUND
  • Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, Andreasson U, Norgren N, Blennow K, Zetterberg H. Serum Neurofilament Light in American Football Athletes over the Course of a Season. J Neurotrauma. 2016 Oct 1;33(19):1784-1789. doi: 10.1089/neu.2015.4295. Epub 2016 Mar 16.

    PMID: 26700106BACKGROUND
  • Oliver JM, Anzalone AJ, Stone JD, Turner SM, Blueitt D, Garrison JC, Askow AT, Luedke JA, Jagim AR. Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season. J Neurosurg. 2018 May 29;130(5):1655-1662. doi: 10.3171/2017.12.JNS172035. Print 2019 May 1.

    PMID: 29807487BACKGROUND
  • Shahim P, Zetterberg H, Tegner Y, Blennow K. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017 May 9;88(19):1788-1794. doi: 10.1212/WNL.0000000000003912. Epub 2017 Apr 12.

    PMID: 28404801BACKGROUND
  • Joseph JR, Swallow JS, Willsey K, Lapointe AP, Khalatbari S, Korley FK, Oppenlander ME, Park P, Szerlip NJ, Broglio SP. Elevated markers of brain injury as a result of clinically asymptomatic high-acceleration head impacts in high-school football athletes. J Neurosurg. 2018 Jul 3;130(5):1642-1648. doi: 10.3171/2017.12.JNS172386. Print 2019 May 1.

    PMID: 29966462BACKGROUND
  • Tierney GJ, Higgins B. The incidence and mechanism of heading in European professional football players over three seasons. Scand J Med Sci Sports. 2021 Apr;31(4):875-883. doi: 10.1111/sms.13900. Epub 2021 Jan 18.

    PMID: 33280186BACKGROUND
  • Peek K, Vella T, Meyer T, Beaudouin F, McKay M. The incidence and characteristics of purposeful heading in male and female youth football (soccer) within Australia. J Sci Med Sport. 2021 Jun;24(6):603-608. doi: 10.1016/j.jsams.2020.12.010. Epub 2020 Dec 26.

    PMID: 33414022BACKGROUND
  • Russell ER, Mackay DF, Stewart K, MacLean JA, Pell JP, Stewart W. Association of Field Position and Career Length With Risk of Neurodegenerative Disease in Male Former Professional Soccer Players. JAMA Neurol. 2021 Sep 1;78(9):1057-1063. doi: 10.1001/jamaneurol.2021.2403.

    PMID: 34338724BACKGROUND
  • Mackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W. Neurodegenerative Disease Mortality among Former Professional Soccer Players. N Engl J Med. 2019 Nov 7;381(19):1801-1808. doi: 10.1056/NEJMoa1908483. Epub 2019 Oct 21.

    PMID: 31633894BACKGROUND
  • Kawata K, Tierney R, Phillips J, Jeka JJ. Effect of Repetitive Sub-concussive Head Impacts on Ocular Near Point of Convergence. Int J Sports Med. 2016 May;37(5):405-10. doi: 10.1055/s-0035-1569290. Epub 2016 Feb 9.

    PMID: 26859643BACKGROUND

Study Officials

  • Keisuke Kawata, PhD

    Indiana University Bloomington Department of Kineseology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Keisuke Kawata, PhD

CONTACT

Blair Johnson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The blood biomarker experimentalist and lead statistician will be masked throughout the trial.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The short interval group will be assigned to undergo 16 soccer headings twice per week, with 24 hours in between each heading session. The long interval group will be assigned to undergo 16 soccer headings twice per week, with 72 hours in between each heading session. The control group that perform soccer kicking, instead of heading, will also have long and short intervals, identical to the heading group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 30, 2025

First Posted

June 8, 2025

Study Start

August 5, 2025

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations